Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. - Wikidata - awgldk - TriplyDB

Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration.

Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration.

http://www.wikidata.org/entity/Q42244715

about

Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B The Role of cccDNA in HBV Maintenance.T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model.Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.Validation of cross-genotype neutralization by hepatitis B virus-specific monoclonal antibodies by in vitro and in vivo infection.Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation.Humanized Mouse Models of Clinical Disease.Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice.Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice.Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection.Haem oxygenase-1 polymorphisms can affect HCV replication and treatment responses with different efficacy in humanized mice.Immunofluorescent Staining for the Detection of the Hepatitis B Core Antigen in Frozen Liver Sections of Human Liver Chimeric Mice.Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells.Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.

P2860

Q27318089-88A57057-B61E-40BD-AE46-7619FFECCFFA Q32182914-2C57F5DB-CA04-475E-8CA2-A93D3AB681F6 Q33683128-12F983FC-30A0-4D23-BA61-5C1F8F4D63B0 Q33807794-74ECD7A2-ADA2-4C22-A15F-8C36EEAB3516 Q34289969-64DF897F-EE51-43E2-A920-CB66713EE5E4 Q35097179-115332A8-DEA2-462A-AE07-6E098CAEEDC9 Q36073739-E335A31F-EE64-43ED-833D-D4799FCEA9EB Q36207245-11512F8E-79FB-4A71-8163-17DDA1930EE5 Q37614202-58C25366-DFFF-430F-8F6C-72B3ADA7338E Q38295860-45440599-110D-4629-82C1-3B5A10018603 Q38553065-698EEA4A-A6DC-4AE5-8DBE-13680ACF6258 Q38665181-AA06E8D8-FF8F-491A-A2E8-AB13D0F29A32 Q38837061-D9B8AEDF-3445-48CE-97D1-5A0D355EF510 Q39322379-5C65765F-5164-4160-A35D-C1FCBF11C26B Q40082002-95960254-C7FF-4771-B85D-03549D7DE7A3 Q40127647-1C9D9C13-CD00-4A01-A825-7D0B42109763 Q40398599-F83C902B-B64D-486D-A945-2B3C229D739F Q40404324-AB22F556-6810-4F4A-A607-683748582F16 Q40409360-145455F1-F7BC-4BC7-A730-B72EC8F2219C Q40685406-CE5C67FA-93FF-496A-B624-53BE7CDBC31F Q49997050-0BF36F87-EA7B-4B68-869A-26AFA8A72CF1

P2860

Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration.

http://www.wikidata.org/entity/Q42244715

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Immune cell responses are not ...... terferon-alpha administration.

@en

Immune cell responses are not ...... terferon-alpha administration.

@nl

type

label

Immune cell responses are not ...... terferon-alpha administration.

@en

Immune cell responses are not ...... terferon-alpha administration.

@nl

prefLabel

Immune cell responses are not ...... terferon-alpha administration.

@en

Immune cell responses are not ...... terferon-alpha administration.

@nl

P1433

Q42244715-32D87AB0-D65A-4F3D-A66B-F28F89A4092D

P1476

Q42244715-D2AD8278-101F-4635-8380-846B7265BAB2

P2093

Q42244715-200A234B-BBDC-45A2-9D8C-D56517E20220

Q42244715-7024A4F0-EEF6-4E8D-82C8-A92F5BC65D23

Q42244715-970B2C9B-C179-4EF9-AA6A-C5631C7FDFE9

Q42244715-A12F1B6B-E68E-43A0-B247-CADBCCC5B1DE

Q42244715-A5012B67-EEDB-4B9F-B7FE-C25F255F2F02

Q42244715-B2673CF2-ED87-4ECA-827D-AA34FC4175D4

Q42244715-B9155D12-1FDB-4FA8-9AC1-7B770DA32264

Q42244715-C8311706-9B97-4738-B06D-9E9B96026C6A

Q42244715-F69FACBE-C2FE-4F42-B1C9-12E6E93E2591

Q42244715-FE3725EF-E915-472A-876E-866B6BC9507E

P304

Q42244715-743B89B4-9A87-42DE-A9A4-4256FEB3EC89

P31

Q42244715-6FD4E49E-05CE-465A-B687-49FF70770D14

P356

Q42244715-B0DF6873-B956-4BCA-8E68-725715A8C495

P433

Q42244715-1CE79DA4-4172-4F5A-B7CE-4AF9434EA224

P478

Q42244715-6926D922-FA24-4A91-BC5D-4D3D7A9DB567

P50

Q42244715-33FC0294-A904-4F93-8B8A-E090CA7476E0

P577

Q42244715-3041969F-CF9B-48F2-988E-168652817FAD

P5875

Q42244715-57D6CE6E-0569-4AC4-BEF4-28A2531923BC

P698

Q42244715-42C2E9D0-D0F5-4464-85A2-4C3D6EF21A0F

P356

J.JHEP.2013.10.021

P1433

Journal of Hepatology

P1476

Immune cell responses are not ...... nterferon-alpha administration

@en

P2093

Ansgar W Lohse

http://www.w3.org/2001/XMLSchema#string

Han Ma

http://www.w3.org/2001/XMLSchema#string

Joerg Petersen

http://www.w3.org/2001/XMLSchema#string

Katja Giersch

http://www.w3.org/2001/XMLSchema#string

Klaus Klumpp

http://www.w3.org/2001/XMLSchema#string

Lena Allweiss

http://www.w3.org/2001/XMLSchema#string

Marc Lütgehetmann

http://www.w3.org/2001/XMLSchema#string

Maura Dandri

http://www.w3.org/2001/XMLSchema#string

Simon P Fletcher

http://www.w3.org/2001/XMLSchema#string

Till Bornscheuer

http://www.w3.org/2001/XMLSchema#string

P304

500-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2013.10.021

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259626627

http://www.w3.org/2001/XMLSchema#string

P698

24398036

http://www.w3.org/2001/XMLSchema#string